Dr. Rachel M. Holden is a nephrologist and a Professor in the Department of Medicine with a cross-appointment to the Department of Biomedical and Molecular Sciences at Queen's University. She joined the faculty in 2001.
She currently holds a Clinician Scientist award. Dr. Holden and her associates study basic mechanisms of vascular calcification in chronic kidney disease. A focus of her research program is clinical, basic and translational aspects of vitamin K metabolism and specifically the role of vitamin K in the inhibition of vascular calcification.
Dr. Holden's clinical interests include mineral bone disorders in chronic kidney disease and hemodialysis patients.